152 related articles for article (PubMed ID: 886962)
21. Peripheral vascular circulation in patients with rheumatoid arthritis influence of papaverine.
Batterman RC; Jensen G; Jensen L
Angiology; 1970 Oct; 21(9):612-26. PubMed ID: 5457224
[No Abstract] [Full Text] [Related]
22. [Clinical trial of fenoxedil in peripheral artery diseases].
Warembourg H; Thery C
Lille Med; 1976 Jan; 21(1 suppl 1):4-7. PubMed ID: 1256230
[No Abstract] [Full Text] [Related]
23. [Comparative study of various schedules of buflomedil treatment in peripheral arterial insufficiency of the lower limbs. Evaluation of its therapeutic efficacy].
Paoletti V; Mammarella A; Alessandrini A; Barlattani M
Clin Ter; 1984 Jul; 110(1):29-36. PubMed ID: 6237843
[No Abstract] [Full Text] [Related]
24. [Experiences with Trental in peripheral circulatory disorders and cerebrovascular insufficiency (author's transl)].
Schafé MK
Munch Med Wochenschr; 1973 Oct; 115(40):1745-9. PubMed ID: 4801042
[No Abstract] [Full Text] [Related]
25. [Clinical use of thymoxamine in peripheral arterial pathology].
Ghiglino GC; Viacava A; Gori A; Misuri A; Lucertini G; Pelagatti M
Clin Ter; 1983 Apr; 105(2):103-7. PubMed ID: 6222862
[No Abstract] [Full Text] [Related]
26. [Ifenprodil tartrate in the treatment of occlusive arteriopathies of the lower limbs. Results of a prospective double-blind controlled multicenter trial].
Natali J; Kieny R; Le Bas P; Benhamou M; Molkhou JM
Ann Cardiol Angeiol (Paris); 1989 Jun; 38(6):339-42. PubMed ID: 2667444
[No Abstract] [Full Text] [Related]
27. [Objective data on the action of piribedil in disorders of the peripheral arterial circulation].
Royer RJ
Minerva Med; 1976 May; 67(25):1656-61. PubMed ID: 778667
[No Abstract] [Full Text] [Related]
28. [Vasodilators and arteriopathies of the lower extremities].
Mazzola C
Soins; 1978 Nov; 23(22):35-6, 38. PubMed ID: 31689
[No Abstract] [Full Text] [Related]
29. [Buflomedil chlorhydrate in peripheral vasculopathies].
Dall'Antonia F; Perbellini A; Adami CA; Dal Cortivo G; Bucci S
Clin Ter; 1986 Dec; 119(5):379-85. PubMed ID: 2951055
[No Abstract] [Full Text] [Related]
30. [Indications for and effects of vasodilating agents, especially in cerebral and peripheral vascular sclerosis].
Offerhaus L
Ned Tijdschr Geneeskd; 1981 Feb; 125(6):228-34. PubMed ID: 7207673
[No Abstract] [Full Text] [Related]
31. [Intra-arterial infusion therapy in thrombo-obliterating diseases of the lower limbs].
Kurbangaleev SM; Savel'ev IuS
Vestn Khir Im I I Grek; 1974 Oct; 113(10):68-71. PubMed ID: 4432347
[No Abstract] [Full Text] [Related]
32. [Effects of the administration of buflomedil-hydrochloride on the arterial circulation of the legs in patients with obliterative arteriopathies].
Tallarida G; Baldoni F; Peruzzi G; Raimondi G; Grimaldi I; Visigalli G; Gristina S; Massaro M; De Martinis L; Sangiorgi M
Cardiologia; 1983 Aug; 28(8):651-60. PubMed ID: 6687209
[No Abstract] [Full Text] [Related]
33. The arteriolar effects of cinnarizine and flunarizine. Multitechnical investigations in normal volunteers and in patients with occlusive disease of the extremities secondary to arteriosclerosis.
Verhaegen H; Roels V; Adriaensen H; Brugmans J; De Cock W; Dony J; Jageneau A; Schuermans V
Angiology; 1974 Apr; 25(4):261-78. PubMed ID: 4818724
[No Abstract] [Full Text] [Related]
34. [Clinical experience and instrumental evaluation of buflomedil hydrochloride in the therapy of chronic obliterative arteriopathies of the legs].
Lucisano V; Margheriti R; Matone P; Morrieri C; Rugolo A; Corsi V
Clin Ter; 1986 Jun; 117(6):499-509. PubMed ID: 3527536
[No Abstract] [Full Text] [Related]
35. [Current news in the pharmacological and surgical treatment of chronic, peripheral, obliterating arterial diseases of the lower limbs].
Argenteri A; Bagliani A; Borri P; Ugolini U
Clin Ter; 1974 Aug; 70(3):281-91. PubMed ID: 4423739
[No Abstract] [Full Text] [Related]
36. [Relationship between blood flow values of the upper and the lower extremities and effects of a vasoactive agent in persons with normal circulation and patients with vascular diseases].
Caesar K
Med Welt; 1971 Apr; 14():559-62. PubMed ID: 5551942
[No Abstract] [Full Text] [Related]
37. [Double-blind study of naftidrofuryl-hydrogen oxalate in peripheral arterial occlusive disease].
Pohle W; Hirche H; Barmeyer J; Schümichen C; Hoffmann G
Med Welt; 1979 Feb; 30(7):269-72. PubMed ID: 372733
[No Abstract] [Full Text] [Related]
38. [Clinical trial of a new vasoactive drug F.I. 6714 administered intra-arterially in peripheral vascular diseases].
Masini G
Minerva Cardioangiol; 1975 Feb; 23(2):120-5. PubMed ID: 1095956
[No Abstract] [Full Text] [Related]
39. Vasodilator drugs in peripheral vascular disease.
Coffman JD
J Maine Med Assoc; 1975 Oct; 66(10):262-9. PubMed ID: 1104731
[No Abstract] [Full Text] [Related]
40. Efficacy and limits of sildenafil citrate in patients with arterial erectile dysfunction: role of peripheral arterial disease and cardiovascular comorbidities.
Vicari E; Malaguarnera M; La Vignera S; Calzavara F; Battiato C; Calogero AE
Asian J Androl; 2008 Nov; 10(6):847-53. PubMed ID: 18958348
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
